All In MedTech

FDA Clearance Tracker · K011172

ARTHREX BIO-TRANSFIX

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jun 19, 2001 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Jun 19, 2001

Substantially Equivalent

Time to decision

63 days

Received Apr 17, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K011172
Device name
ARTHREX BIO-TRANSFIX
Applicant
Arthrex, Inc.
Applicant location
Naples, FL
Received
Apr 17, 2001
Decided
Jun 19, 2001
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 888.3030

Every decision under product code MNU

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code MNU (Staple, Absorbable).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K011172
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Arthrex, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.